Key result
Patients with diabetes had significantly impaired low-frequency oscillation vasomotion compared to healthy controls (mean amplitude 24.9 vs 129.0; P<0.0039).
Why the study?
Is peripheral vasomotion impaired in diabetic subjects compared with healthy control subjects?
Case-Control (n=40)
Is peripheral vasomotion impaired in diabetic subjects compared with healthy control subjects?
Absolute Event Rate: 24.9% vs 129%
p-value: p=<0.0039
Peripheral vasomotion is significantly impaired in diabetic patients and correlates with warm thermal sensory threshold, suggesting a neurovascular abnormality.
No takes yet. Share an insight, caveat, or question.
Impaired vasomotion in diabetes suggests neurovascular abnormality; leaves open its prognostic value or therapeutic targeting.
Stansberry et al. (1996) conducted a case-control in Diabetes (n=40). Diabetes vs. Healthy control subjects was evaluated on Mean amplitude of low-frequency oscillation vasomotion (p=<0.0039). Patients with diabetes had significantly impaired low-frequency oscillation vasomotion compared to healthy controls (mean amplitude 24.9 vs 129.0; P<0.0039).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: